| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CDW | Common Stock, par value $0.01 | Options Exercise | $1,810,698 | +18,437 | +82% | $98.21 | 40,865 | 16 Jul 2024 | Direct | |
| transaction | CDW | Common Stock, par value $0.01 | Sale | $4,095,524 | -17,037 | -42% | $240.39 | 23,828 | 16 Jul 2024 | Direct | F1, F2 |
| transaction | CDW | Common Stock, par value $0.01 | Sale | $337,596 | -1,400 | -5.9% | $241.14 | 22,428 | 16 Jul 2024 | Direct | F1, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CDW | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -18,437 | -71% | $0.000000 | 7,477 | 16 Jul 2024 | Common Stock, par value $0.01 | 18,437 | $98.21 | Direct | F4 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2024. |
| F2 | The price reported is the average weighted price. The shares were sold in multiple transactions at prices ranging from $240.00 to $240.81, inclusive. The reporting person undertakes to provide to the SEC, the Issuer and any security holder, the full information regarding the number of shares and the prices at which the shares were sold. |
| F3 | The price reported is the average weighted price. The shares were sold in multiple transactions at prices ranging from $241.12 to $241.19 , inclusive. The reporting person undertakes to provide to the SEC, the Issuer and any security holder, the full information regarding the number of shares and the prices at which the shares were sold. |
| F4 | 51,828 options were granted of which one third of the shares vested on each of March 9, 2021, 2022, and 2023. The grant was made under the CDW Corporation Long-Term Incentive Plan. |
Chief Growth and Innovation Officer